Growth following solid organ transplantation in childhood
One of the ultimate goals of successful solid organ transplantation in pediatric recipients is attaining an optimal final adult height. This manuscript will discuss growth following transplantation in pediatric recipients of kidney, liver, heart, lung or small bowel transplants. Remarkably similar f...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2014-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001300003&lng=en&tlng=en |
id |
doaj-eb2cf70f355147f99d8d45b33e7265ad |
---|---|
record_format |
Article |
spelling |
doaj-eb2cf70f355147f99d8d45b33e7265ad2020-11-25T00:16:53ZengFaculdade de Medicina / USPClinics1980-53222014-01-0169suppl 13710.6061/clinics/2014(Sup01)02S1807-59322014001300003Growth following solid organ transplantation in childhoodRichard N. FineOne of the ultimate goals of successful solid organ transplantation in pediatric recipients is attaining an optimal final adult height. This manuscript will discuss growth following transplantation in pediatric recipients of kidney, liver, heart, lung or small bowel transplants. Remarkably similar factors impact growth in all of these recipients. Age is a primary factor, with younger recipients exhibiting the greatest immediate catch-up growth. Graft function is a significant contributing factor, with a reduced glomerular filtration rate correlating with poor growth in kidney recipients and the need for re-transplantation with impaired growth in liver recipients. The known adverse impact of steroids on growth has led to modification of the steroid dose and even steroid withdrawal and avoidance. In kidney and liver recipients, this strategy has been associated with the development of acute rejection. In infant heart transplantation, avoiding maintenance corticosteroid immunosuppression is associated with normal growth velocity in the majority of patients. With marked improvements in patient and graft survival rates in pediatric organ recipients, quality of life issues, such as normal adult height, should now receive paramount attention. In general, normal growth following solid organ transplantation should be an achievable goal that results in normal adult height.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001300003&lng=en&tlng=enGrowthSolid Organ TransplantationChildrenGrowth HormoneSteroid Avoidance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Richard N. Fine |
spellingShingle |
Richard N. Fine Growth following solid organ transplantation in childhood Clinics Growth Solid Organ Transplantation Children Growth Hormone Steroid Avoidance |
author_facet |
Richard N. Fine |
author_sort |
Richard N. Fine |
title |
Growth following solid organ transplantation in childhood |
title_short |
Growth following solid organ transplantation in childhood |
title_full |
Growth following solid organ transplantation in childhood |
title_fullStr |
Growth following solid organ transplantation in childhood |
title_full_unstemmed |
Growth following solid organ transplantation in childhood |
title_sort |
growth following solid organ transplantation in childhood |
publisher |
Faculdade de Medicina / USP |
series |
Clinics |
issn |
1980-5322 |
publishDate |
2014-01-01 |
description |
One of the ultimate goals of successful solid organ transplantation in pediatric recipients is attaining an optimal final adult height. This manuscript will discuss growth following transplantation in pediatric recipients of kidney, liver, heart, lung or small bowel transplants. Remarkably similar factors impact growth in all of these recipients. Age is a primary factor, with younger recipients exhibiting the greatest immediate catch-up growth. Graft function is a significant contributing factor, with a reduced glomerular filtration rate correlating with poor growth in kidney recipients and the need for re-transplantation with impaired growth in liver recipients. The known adverse impact of steroids on growth has led to modification of the steroid dose and even steroid withdrawal and avoidance. In kidney and liver recipients, this strategy has been associated with the development of acute rejection. In infant heart transplantation, avoiding maintenance corticosteroid immunosuppression is associated with normal growth velocity in the majority of patients. With marked improvements in patient and graft survival rates in pediatric organ recipients, quality of life issues, such as normal adult height, should now receive paramount attention. In general, normal growth following solid organ transplantation should be an achievable goal that results in normal adult height. |
topic |
Growth Solid Organ Transplantation Children Growth Hormone Steroid Avoidance |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001300003&lng=en&tlng=en |
work_keys_str_mv |
AT richardnfine growthfollowingsolidorgantransplantationinchildhood |
_version_ |
1725381949006020608 |